'I'm sure it's cost and cost alone': B.C. only province in Canada that won't cover multiple sclerosis drug
Cranbook teacher Andrea Rollheiser was 32 years old when she first had symptoms of optic neuritis. But it was three years before she was officially diagnosed with relapsing remitting multiple sclerosis, or RRMS.
“The diagnosis itself definitely explained a lot of symptoms and things I have felt over the years,” said Rollheiser, who is now 42-years-old and on medical leave from her teaching position.
After a serious relapse impacted her mobility and landed her in hospital last year, she learned about a drug that could lessen the number and severity of future relapses.
“So that drug is Ocrevus. And Ocrevus is not approved in B.C. for use in patients with RRMS. It is approved for patients with primary progressive MS. That is not me,” said Rollheiser.
Every other province and territory covers Ocrevus, which has been approved by Health Canada and gone through two large-scale clinical trials for relapsing remitting MS patients. But B.C. pharmacare won’t cover it.
“They replace it with one of these generic medications which has actually never been tested in proper control studies for multiple sclerosis,” said Dr. Freedman, director of the MS research unit at Ottawa Hospital. “I’m sure it’s cost and cost alone that is driving B.C. Pharmacare to make this decision.”
In a statement, the B.C. health ministry said: “The national Common Drug Review evaluates a drug based on its therapeutic value and cost effectiveness and makes recommendations to provincial drug plans. B.C.’s Drug Benefit Council then takes that recommendation into consideration when reviewing the drug and makes its own recommendation to the ministry.”
Rollheiser said the decision not to cover Ocrevus could have dire consequences for British Columbians like her.
“I was told my next relapse will be most likely severe again. That there needs to be intervention, there needs to be drug intervention,” she said.
Her private insurance won’t cover the twice a year Ocrevus infusions, and like most MS patients, she can’t afford the out-of-pocket cost of $33,000.
“And it’s frustrating to know that just a province over, I could be covered and be on this drug,” said Rollheiser.
Dr. Freedman believes every RRMS patient in Canada should have access to the Ocrevus.
“My colleagues have exhausted themselves writing to government and pleading for the use of the approved therapies, so I think it’s got to come from the grass roots, it’s got to be the people,” Freedman said.
That’s why Rollheiser is speaking out, hoping her story convinces the B.C. government to take another look at Ocrevus.
“These drugs are expensive, however every other province and territory has approved them for use with their MS patients,” she said. “It is very hard to think this is 2023, that this is Canada, and that my quality of my future life is being effected today by not being on these drugs.
CTVNews.ca Top Stories
Grandparents killed in wrong-way crash on Hwy. 401 identified
A 60-year-old man and a 55-year-old woman killed in a wrong-way crash on Highway 401 earlier this week have been identified by the Consulate General of India in Toronto.
Police arrest 3 Indian nationals in killing of B.C. Sikh activist Hardeep Singh Nijjar
Three people have been arrested and charged in the killing of B.C. Sikh activist Hardeep Singh Nijjar – as authorities continue investigating potential connections to the Indian government.
Suter scores late goal, clinches series for Canucks
Pius Suter scored with 1:39 left and the Vancouver Canucks advanced to the second round of the NHL playoffs with a 1-0 victory over the Nashville Predators on Friday night in Game 6.
TD worst-case scenario more likely after drug money laundering allegations: analyst
TD Bank Group could be hit with more severe penalties than previously expected, says a banking analyst after a report that the investigation it faces in the U.S. is tied to laundering illicit fentanyl profits.
Quebec man who threatened Trudeau, Legault online sentenced to 20 months in jail
A Quebec man who pleaded guilty to threatening Prime Minister Justin Trudeau and Premier François Legault has been sentenced to 20 months in jail.
Human remains found in rural Sask. possibly a decade old, RCMP say
RCMP say human remains found in a rural area in central Saskatchewan may have been there for a decade or more.
Britney Spears 'home and safe' after paramedics responded to an incident at the Chateau Marmont, source tells CNN
A source close to singer Britney Spears tells CNN that the pop star is 'home and safe' after she had a 'major fight' with her boyfriend on Wednesday night at the Chateau Marmont in West Hollywood.
Canadian doctor concerned new weight-loss drug Wegovy may be used inappropriately
As Wegovy becomes available to Canadians starting Monday, a medical expert is cautioning patients wanting to use the drug to lose weight that no medication is a ''magic bullet,' and the new medication is meant particularly for people who meet certain criteria related to obesity and weight.
Drew Carey is never quitting 'The Price Is Right'
Drew Carey took over as host of 'The Price Is Right' and hopes he’s there for life. 'I'm not going anywhere,' he told 'Entertainment Tonight' of the job he took over from longtime host Bob Barker in 2007.